John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Knight Transportation
KNX
$11.2B
| $4.89M | 0.01% |
96,934
+37,302
| +63% | +$2.06M |
|
927
10x Genomics
TXG
$8.31B
| $4.87M | 0.01% |
+64,038
| New | +$5.6M |
|
928
Teva Pharmaceuticals
TEVA
$43B
| $4.86M | 0.01% |
517,049
-463,147
| -47% | -$3.87M |
|
929
KraneShares CSI China Internet ETF
KWEB
$5.18B
| $4.85M | 0.01% |
170,000
+50,000
| +42% | +$1.68M |
|
930
AbCellera Biologics
ABCL
$3.44B
| $4.84M | 0.01% |
495,984
-19,616
| -4% | -$186K |
|
|
DCH
931
Dauch Corp
DCH
$1.53B
| $4.83M | 0.01% |
+622,510
| New | +$5.31M |
|
932
Agree Realty
ADC
$9.28B
| $4.83M | 0.01% |
72,712
-132,017
| -64% | -$8.59M |
|
933
Columbia Banking Systems
COLB
$8.67B
| $4.81M | 0.01% |
149,192
-25,208
| -14% | -$884K |
|
|
PNNT
934
Pennant Park Investment Corp
PNNT
$246M
| $4.81M | 0.01% |
618,764
+216,125
| +54% | +$1.6M |
|
935
McCormick & Company Non-Voting
MKC
$15.1B
| $4.79M | 0.01% |
+47,950
| New | +$4.69M |
|
936
Expedia Group
EXPE
$40.7B
| $4.78M | 0.01% |
24,401
-43,044
| -64% | -$8.05M |
|
|
EXPR
937
DELISTED
Express, Inc.
EXPR
| $4.78M | 0.01% |
67,062
-5,964
| -8% | -$438K |
|
938
Oramed Pharmaceuticals
ORMP
$200M
| $4.77M | 0.01% |
550,956
+148,859
| +37% | +$1.53M |
|
939
Packaging Corp of America
PKG
$22.2B
| $4.76M | 0.01% |
30,503
-20,354
| -40% | -$2.97M |
|
940
Huron Consulting
HURN
$2.59B
| $4.75M | 0.01% |
103,678
+98,229
| +1,803% | +$4.53M |
|
941
A10 Networks
ATEN
$1.83B
| $4.75M | 0.01% |
340,269
-301,373
| -47% | -$4.24M |
|
942
Telos
TLS
$327M
| $4.7M | 0.01% |
471,639
+402,739
| +585% | +$4.52M |
|
|
UMH
943
UMH Properties
UMH
$1.42B
| $4.7M | 0.01% |
191,169
+148,460
| +348% | +$3.57M |
|
944
Smith & Nephew
SNN
$12.4B
| $4.69M | 0.01% |
+146,992
| New | +$4.93M |
|
945
Live Oak Bancshares
LOB
$1.87B
| $4.68M | 0.01% |
91,875
+85,775
| +1,406% | +$5.49M |
|
|
ARGO
946
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $4.67M | 0.01% |
113,009
+106,962
| +1,769% | +$5.13M |
|
947
CALL
Algonquin Power & Utilities
AQN
$4.38B
| $4.66M | 0.01% |
+300,000
| New | +$4.33M |
|
|
TRTX
948
TPG RE Finance Trust
TRTX
$600M
| $4.64M | 0.01% |
392,708
+270,807
| +222% | +$3.3M |
|
949
Warner Music
WMG
$14.5B
| $4.63M | 0.01% |
122,300
-392,851
| -76% | -$14.9M |
|
950
Veeco
VECO
$2.86B
| $4.61M | 0.01% |
169,424
-87,479
| -34% | -$2.46M |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.